COA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing FacilitiesCOA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing Facilities
Selank 10 mg
Selank 10 mg - Image 2

Selank 10 mg

Selank, a synthetic tuftsin-derived peptide studied in anxiolytic and nootropic research, 10 mg. For research purposes only.

🇨🇦 Canadian First Lyfe is the first manufacturer of dual chamber pens in Canada. Learn More →

Description

Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, studied as an anxiolytic and nootropic research compound.

Commonly explored in research for:

  • Anxiety-related behaviour and stress models
  • Cognition, memory and attention research
  • BDNF and neurotransmitter (GABA, serotonin) modulation
  • Immune-modulating activity

Supplied as 10 mg lyophilized powder for reconstitution.

⚖️

Chemical Overview

Key identifiers & structural data

🔬 Structural Data

About Selank

ClassificationSynthetic peptide
CAS Registry129954-34-3
Molecular Mass751.9
Residue Count7
Chain SequenceThr-Lys-Pro-Arg
Molecular FormulaC33H57N11O9
🔗 View on PubChem
📑

Research Literature

Published studies & clinical data

Bulletin of Experimental Biology and Medicine

Selank: a novel anxiolytic peptide

2002 • PMID: 12459874

Myasoedov NF, Andreeva LA, Gudasheva TA

Read Paper ↗
Neuroscience and Behavioral Physiology

Selank and its effects on the central nervous system

2008 • PMID: 18607712

Ashmarin IP, Grivennikov IA, Kamensky AA

Read Paper ↗
Doklady Biological Sciences

Selank: a novel neuroprotective peptide

2009 • PMID: 19334514

Ashmarin IP, Grivennikov IA, Kamensky AA

Read Paper ↗

Related products